Ukr.Biochem.J. 2011; Volume 83, Issue 6, Nov-Dec, pp. 70-75


Growth hormone, growth hormone receptor and insulin-like growth factor serum levels in patients with obesity and food addiction

O. Avsar1*, S. Sancak2, I. Koroglu3, E. Avci4

1Hitit University, Department of Molecular Biology and Genetics, Corum, Turkey;
2Fatih Sultan Mehmet Education and Research Hospital, Department of Endocrinology, Istanbul, Turkey;
3Arapgir Ali Özge State Hospital, Department of Internal Medicine, Malatya, Turkey;
4Health Sciences University, Department of Biochemistry, Ankara, Turkey;

Received: 27 May 2021; Accepted: 12 November 2021

Obesity is a public health problem that increasingly becomes widespread and causes various complications. Food addiction is a hedonic eating behavior characterized by overconsumption of palatable foods (i.e., foods involve a high amount of salt, sugar and fat). Disturbances in the growth hormone signaling pathway were shown to be associated with increased food intake and adiposity. The study aimed to determine the growth hormone (GH), growth hormone receptor (GHR), insulin, and insulin-like growth factor 1 (IGF-1) serum levels in individuals with obesity and food addiction. The present study involved 30 adults with obesity (23 females and 7 males) and 10 healthy adults (5 females and 5 males). 18 obese adults were diagnosed with food addiction, whereas only 2 individuals with food addiction were in the control group. GH, GHR, IGF-1 and insulin values were analyzed with ELISA kits. It was revealed that the obese subjects had significantly lower serum IGF-1 levels compared to healthy individuals (144.55±22.69 ng/ml vs 338.70±61.90 ng/ml, P < 0.001)). No significant differences in the GH, GHR and insulin levels between obese and control groups were detected (P > 0.05). No significant differences between the group with food addiction and the group without food addiction in terms of gender, age, weight, BMI, GH, GHR, insulin and IGF-1 levels were observed. Our study demonstrates that normal IGF-1 levels may be protective for the development of obesity. The serum levels of GH, GHR, insulin, IGF-1 are not associated with food addiction and, therefore, can not be used as novel markers of food addiction.

Keywords: , , , ,


  1. Aktar N, Qureshi NK, Ferdous HS. Obesity: A review of pathogenesis and management strategies in adult.  Delta Med Coll J. 2017;5(1):35-48.
  2. Novelle MG, Diéguez C. Food Addiction and Binge Eating: Lessons Learned from Animal Models. Nutrients. 2018;10(1):71. PubMed, PubMedCentral, CrossRef
  3. Schulte EM, Joyner MA, Potenz MN, Grilo CM, Gearhardt AN. Current considerations regarding food addiction. Curr Psychiatry Rep. 2015;17(4):563. PubMed, CrossRef
  4. Ayaz A, Nergiz-Unal R, Dedebayraktar D, Akyol A, Pekcan AG, Besler HT, Buyuktuncer Z. How does food addiction influence dietary intake profile? PLoS One. 2018;13(4):e0195541.  PubMed, PubMedCentral, CrossRef
  5. Mendoza J. Food intake and addictive-like eating behaviors: Time to think about the circadian clock(s). Neurosci Biobehav Rev. 2019;106:122-132. PubMed, CrossRef
  6. Vijayakumar A, Yakar S, Leroith D. The intricate role of growth hormone in metabolism. Front Endocrinol (Lausanne). 2011;2:32. PubMed, PubMedCentral, CrossRef
  7. Nishad R, Mukhi D, Menon RK, Pasupulati AK. Growth hormone and metabolic homeostasis. Eur Med J Diabetes. 2018;6(1):78-87.
  8. Salvatori R. Growth hormone deficiency in patients with obesity. Endocrine. 2015;49(2):304-306. PubMed, CrossRef
  9. Recinella L, Leone S, Ferrante C, Chiavaroli A, Shohreh R , Di Nisio C, Vacca M, Orlando G, Salvatori R, Brunetti L. Effects of growth hormone-releasing hormone gene targeted ablation on ghrelin-induced feeding. Growth Horm IGF Res. 2017;37:40-46. PubMed, CrossRef
  10. Rasmussen MH. Obesity, growth hormone and weight loss. Mol Cell Endocrinol. 2010;316(2):147-153. PubMed, CrossRef
  11. Gearhardt AN, Corbin WR, Brownell KD. Preliminary validation of the Yale Food Addiction Scale. Appetite. 2009;52(2):430-436. PubMed, CrossRef
  12. Bayraktar F, Erkman F, Kurtuluş E. Adaptation study of Yale food addiction Scale. Bull Clin Psychopharm. 2012;22(Suppl 1):S38.
  13. Avsar O, Kuskucu A, Sancak S, Genc E. Are dopaminergic genotypes risk factors for eating behavior and obesity in adults? Neurosci Lett. 2017;654:28-32. PubMed, CrossRef
  14. Dehkhoda F, Lee CMM, Medina J, Brooks AJ. The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects. Front Endocrinol (Lausanne). 2018;9:35. PubMed, PubMedCentral, CrossRef
  15. Kreitschmann-Andermahr I, Suarez P, Jennings R, Evers N, Brabant G.GH/IGF-I regulation in obesity–mechanisms and practical consequences in children and adults. Horm Res Paediatr. 2010;73(3):153-160.  PubMed, CrossRef
  16. Guevara-Aguirre J, Teran E, Lescano D, Guevara A , Guevara C, Longo V, Gavilanes AWD. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity. Growth Horm IGF Res. 2020;51:58-64. PubMed, CrossRef
  17. Erman A, Veilleux A, Tchernof A, Goodyer CG. Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women. Int J Obes (Lond). 2011;35(12):1511-1519. PubMed, CrossRef
  18. Lewitt MS. The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity. Biochem Insights. 2017;10:1178626417703995. PubMed, PubMedCentral, CrossRef
  19. Juiz-Valiña P, Pena-Bello L, Cordido M, Outeiriño-Blanco E, Pértega S, Varela-Rodriguez B, Garcia-Brao MJ, Mena E, Sangiao-Alvarellos S, Cordido F.  Altered GH-IGF-1 Axis in Severe Obese Subjects is Reversed after Bariatric Surgery-Induced Weight Loss and Related with Low-Grade Chronic Inflammation. J Clin Med. 2020;9(8):2614. PubMed, PubMedCentral, CrossRef
  20. Bancu I, Díaz MN, Serra A, Granada M, Lopez D, Romero R, Bonet J. Low Insulin-Like Growth Factor-1 Level in Obesity Nephropathy: A New Risk Factor? PLoS One. 2016;11(5):e0154451. PubMed, PubMedCentral, CrossRef
  21. Brambilla F, Santonastaso P, Caregaro L, Favaro A. Growth hormone and insulin-like growth factor 1 secretions in eating disorders: Correlations with psychopathological aspects of the disorders. Psychiatry Res. 2018;263:233-237. PubMedCrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.